Braze Inc
For the period ended Jan 31, 2024. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 1, 2024
BRZE$46.24+0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows for the years ended
| Fiscal Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||
| Net loss (including amounts attributable to redeemable non-controlling interests) | $(130,429) | $(140,746) | $(78,167) |
| Adjustments to reconcile net loss to net cash provided by/(used in) operating activities: | |||
| Stock-based compensation | 97,232 | 72,243 | 47,180 |
| Amortization of deferred contract costs | 29,788 | 23,639 | 17,710 |
| Depreciation and amortization | 6,963 | 4,618 | 2,773 |
| Provision for credit losses | 2,020 | 807 | 88 |
| Value of common stock donated to charity | 3,762 | 4,260 | — |
| (Accretion) amortization of (discount) premium on marketable securities | (2,077) | 1,336 | 369 |
| Non-cash foreign exchange loss | 460 | 1,612 | 387 |
| Fair value adjustments to contingent consideration | (1,572) | — | — |
| Other | (349) | 495 | (80) |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | (14,008) | (14,650) | (29,821) |
| Prepaid expenses and other current assets | (3,413) | 3,596 | (17,537) |
| Deferred contract costs | (45,119) | (30,469) | (31,967) |
| ROU assets and liabilities | 4,275 | 3,355 | — |
| Other assets | 229 | 1,711 | (4,723) |
| Accounts payable | 3,419 | 906 | 1,649 |
| Accrued expenses and other current liabilities | 20,990 | 5,075 | 6,026 |
| Deferred revenue | 34,108 | 39,894 | 51,471 |
| Other long-term liabilities | 571 | 10 | (756) |
| Net cash provided by/(used in) operating activities | 6,850 | (22,308) | (35,398) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||
| Cash paid for acquisition, net of cash acquired | (16,319) | — | — |
| Purchases of property and equipment | (9,761) | (15,447) | (2,310) |
| Capitalized internal-use software costs | (3,574) | (1,258) | (2,065) |
| Purchases of marketable securities | (248,059) | (638,221) | (36,894) |
| Maturities of marketable securities | 257,737 | 256,407 | 59,309 |
| Net cash (used in)/provided by investing activities | (19,976) | (398,519) | 18,040 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||
| Proceeds from issuance of common stock upon initial public offering, net of offering costs | — | — | 462,260 |
| Investment from redeemable non-controlling interest | — | — | 2,450 |
| Proceeds from exercise of common stock options | 7,263 | 11,332 | 8,362 |
| Proceeds from stock associated with employee stock purchase plan | 6,011 | — | — |
| Payment of deferred offering costs | — | — | (5,157) |
| Payments of deferred purchase consideration | (165) | — | — |
| Repurchase of shares related to early exercised options | — | — | (5) |
| Net cash provided by financing activities | 13,109 | 11,332 | 467,910 |
| Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash | (475) | (855) | (597) |
| Net change in cash, cash equivalents, and restricted cash | (492) | (410,350) | 449,955 |
| Cash, cash equivalents, and restricted cash, beginning of period | 72,623 | 482,973 | 33,018 |
| Cash, cash equivalents, and restricted cash, end of period | $72,131 | $72,623 | $482,973 |
SUPPLEMENTAL CASH FLOWS DISCLOSURE
| Fiscal Year Ended January 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| SUPPLEMENTAL CASH FLOW DISCLOSURE: | |||
| Cash paid for income taxes, net of refunds | $309 | $365 | $299 |
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||
| Stock-based compensation capitalized to internal-use software | $2,152 | $1,121 | $387 |
| Net change in capitalized internal-use software development costs in accrued expenses | $— | $21 | $(58) |
| Unrealized net gain (loss) on marketable investment securities | $5,416 | $(5,551) | $(64) |
| Net change to property and equipment (included in accounts payable / accrued liabilities) | $208 | $75 | $(23) |
| Vesting of early exercised options | $— | $145 | $524 |
| Common stock option receivables | $— | $— | $22 |
| Conversion of convertible preferred stock to common stock | $— | $— | $174,229 |
| Deferred offering costs reclassed to Stockholders’ Equity (Deficit) | $— | $— | $183 |
| Asset retirement obligation | $62 | $374 | $— |
| Common stock issuance, acquisition | $(6,121) | $— | $— |
| Contingent consideration, acquisition | $(1,795) | $— | $— |
| Indemnity holdbacks, acquisition | $(3,081) | $— | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.